Inventor · disambiguated record
Ronald Charles Bernotas
Also filed as: BERNOTAS RONALD C · BERNOTAS RONALD CHARLES
39 granted patents·10 pending applications·457 citations·filing 1991–2011
98Inventor score
Top patents by PatentIndex Score
49 records- 0195US7645752B2Sulfonyl substituted 1H-indoles as ligands for the 5-hydroxytryptamine receptorsWYETH LLC·Filed 2007·Granted Jan 12, 2010·59 cites·29 claims
- 0294US7259165B2Heterocyclyl-3-sulfonylazaindole or-azaindazole derivatives as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2004·Granted Aug 21, 2007·72 cites·12 claims
- 0393US7576087B2Heterocyclyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2007·Granted Aug 18, 2009·29 cites·15 claims
- 0490US5292746ACyclic nitrones, pharmaceutical compositions thereof and their use in treating shockMERRELL DOW PHARMA·Filed 1992·Granted Mar 8, 1994·28 cites·34 claims
- 0587US7585876B2Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2007·Granted Sep 8, 2009·8 cites·6 claims
- 0686US6995176B21-heterocyclylalkyl-3-sulfonyl-indole or -indazole derivatives as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2003·Granted Feb 7, 2006·26 cites·14 claims
- 0786US6727246B21-(aminoalkyl)-3-sulfonylindole-and-indazole derivatives as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2003·Granted Apr 27, 2004·29 cites·20 claims
- 0885US7618990B2Oxazolidone derivatives as PR modulatorsWYETH CORP·Filed 2007·Granted Nov 17, 2009·9 cites·24 claims
- 0983US5397789ACyclic nitronesMERRELL DOW PHARMA·Filed 1993·Granted Mar 14, 1995·15 cites·28 claims
- 1082US7576215B2Quinolines and pharmaceutical compositions thereofWYETH CORP·Filed 2004·Granted Aug 18, 2009·21 cites·9 claims
- 1182US6825212B21-(aminoalkyl)-3-sulfonylazaindoles as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2003·Granted Nov 30, 2004·14 cites·15 claims
- 1281US7297705B2Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2004·Granted Nov 20, 2007·8 cites·6 claims
- 1380US7238696B2Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2004·Granted Jul 3, 2007·12 cites·14 claims
- 1479US7411064B21-Heterocyclylalkyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2006·Granted Aug 12, 2008·3 cites·15 claims
- 1579US5559143ASerotonin 5HT1A agonistic methodMERRELL PHARMA INC·Filed 1994·Granted Sep 24, 1996·30 cites·2 claims
- 1678US6800640B2Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2002·Granted Oct 5, 2004·9 cites·14 claims
- 1778US5532252ACyclic nitronesMERRELL PHARMA INC·Filed 1995·Granted Jul 2, 1996·13 cites·25 claims
- 1877US5436246ASerotonin receptor agentsMERRELL DOW PHARMA·Filed 1993·Granted Jul 25, 1995·36 cites·2 claims
- 1971US7291736B2Sulfonyldihydroimidazopyridinone compounds as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2004·Granted Nov 6, 2007·4 cites·7 claims
- 2071US7057039B21-heterocyclylalkyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2003·Granted Jun 6, 2006·4 cites·15 claims
- 2170US7723329B2Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligandsWYETH LLC·Filed 2006·Granted May 25, 2010·1 cites·22 claims
- 2269US6716986B2Sulfuric acid mono-[3-({1-[2-(4-fluoro-phenyl)-ethyl]-piperidin-4-YL}-hydroxy-methyl)-2-methoxy-phenyl]esterAVENTIS PHARMA INC·Filed 2002·Granted Apr 6, 2004·3 cites·14 claims
- 2367US7498327B2Indolylalkylamine metabolites as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2005·Granted Mar 3, 2009·1 cites·20 claims
- 2467US7074792B21-(aminoalkyl)-3-sulfonylazaindoles as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2004·Granted Jul 11, 2006·2 cites·10 claims
- 2563US2009253711A1Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2009·Application pending·0 cites
- 2662US2004152900A1Method for the isolation of sulfuric acid mono-[3({1-[2-(4-fluorophenyly)-ethyl]-piperidin-4-yl}-2-methoxy-phenyl}esterAVENTIS PHARMA INC·Filed 2004·Application pending·0 cites
- 2761US2008306106A11-heterocyclylalkyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2008·Application pending·0 cites
- 2860US7560470B2Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2007·Granted Jul 14, 2009·0 cites·9 claims
- 2959US5498778ACyclic nitrone compounds useful in treating strokeMERRELL DOW PHARMA·Filed 1994·Granted Mar 12, 1996·3 cites·25 claims
- 3058US7608717B2Sulfonyldihydroimidazopyridinone compounds as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2007·Granted Oct 27, 2009·0 cites·9 claims
- 3156US7585873B21-(aminoalkyl)-3-sulfonylazaindoles as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2006·Granted Sep 8, 2009·0 cites·8 claims
- 3256US5387604A1,4 benzodioxin derivatives and their use as serotonin 5HT1A agonistsMERRELL DOW PHARMA·Filed 1992·Granted Feb 7, 1995·9 cites·39 claims
- 3355US5677315ACyclic nitronesMERRELL PHARMA INC·Filed 1995·Granted Oct 14, 1997·3 cites·24 claims
- 3452US7589108B21-Heterocyclylalkyl-3-sulfonylindole or -indazole derivatives as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2005·Granted Sep 15, 2009·0 cites·14 claims
- 3552US6465490B1Sulfuric acid mono-[3({1-[2-(4-fluoro-phenyl)-ethyl]-piperidin-4-yl}-hydroxy-methyl)-2-methoxy-phenyl]esterAVENTIS PHARMA INC·Filed 2000·Granted Oct 15, 2002·3 cites·86 claims
- 3652US2010184786A1Polar QuinazolinesWYETH LLC·Filed 2009·Application pending·0 cites
- 3750US2011112135A1Imidazo [1,2-A] Pyridine CompoundsSINGHAUS JR ROBERT RAY·Filed 2008·Application pending·0 cites
- 3850US2010273816A1Quinazoline CompoundsBERNOTAS RONALD CHARLES·Filed 2008·Application pending·0 cites
- 3950US2011034526A1Benzimidazole CompoundsWYETH LLC·Filed 2008·Application pending·0 cites
- 4049US7538107B2Oxazinan-2-one derivatives useful as PR modulatorsWYETH CORP·Filed 2007·Granted May 26, 2009·0 cites·22 claims
- 4148US7649007B2Oxazolidine derivatives as PR modulatorsWYETH LLC·Filed 2007·Granted Jan 19, 2010·0 cites·20 claims
- 4248US7618989B2Tricyclic oxazolidone derivatives useful as PR modulatorsWYETH CORP·Filed 2007·Granted Nov 17, 2009·0 cites·19 claims
- 4348US7544701B2Sulfonyldihydrobenzimidazolone compounds as 5-hydroxytryptamine-6 ligandsWYETH CORP·Filed 2004·Granted Jun 9, 2009·0 cites·12 claims
- 4448US2009069373A1Quinoline AcidsWYETH CORP·Filed 2008·Application pending·0 cites
- 4545US2007191431A12-Amino-5-piperidinylimidazolone compounds and use thereof for beta-secretase modulationWYETH CORP·Filed 2006·Application pending·0 cites
- 4644US5527812ACyclic nitronesMERRELL PHARMA INC·Filed 1995·Granted Jun 18, 1996·1 cites·25 claims
- 4738US5189179ASerotonin 5ht1a agonistsMERRELL DOW PHARMA·Filed 1991·Granted Feb 23, 1993·2 cites·25 claims
- 4838US2012010205A1Novel quinoline esters useful for treating skin disordersBERNOTAS RONALD CHARLES·Filed 2011·Application pending·0 cites
- 4935US5525615ACyclic nitronesMERRELL PHARMA INC·Filed 1995·Granted Jun 11, 1996·0 cites·25 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →